A detailed history of Banque Pictet & Cie Sa transactions in Abb Vie Inc. stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 99,634 shares of ABBV stock, worth $19.2 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
99,634
Previous 86,337 15.4%
Holding current value
$19.2 Million
Previous $15.7 Million 8.7%
% of portfolio
0.16%
Previous 0.15%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$154.79 - $180.76 $2.06 Million - $2.4 Million
13,297 Added 15.4%
99,634 $17.1 Million
Q1 2024

May 06, 2024

SELL
$159.82 - $182.1 $970,107 - $1.11 Million
-6,070 Reduced 6.57%
86,337 $15.7 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $14.3 Million - $16.1 Million
-103,766 Reduced 52.9%
92,407 $14.3 Million
Q3 2023

Nov 02, 2023

BUY
$133.59 - $154.65 $2.76 Million - $3.2 Million
20,691 Added 11.79%
196,173 $29.2 Million
Q2 2023

Aug 04, 2023

BUY
$132.51 - $164.9 $1.57 Million - $1.95 Million
11,814 Added 7.22%
175,482 $23.6 Million
Q1 2023

May 01, 2023

SELL
$144.61 - $166.54 $1.44 Million - $1.66 Million
-9,950 Reduced 5.73%
163,668 $26.1 Million
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $4.52 Million - $5.42 Million
32,706 Added 23.21%
173,618 $0
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $11.7 Million - $13.4 Million
87,164 Added 162.17%
140,912 $18.9 Billion
Q2 2022

Aug 08, 2022

BUY
$137.62 - $174.96 $7.02 Million - $8.93 Million
51,029 Added 1876.76%
53,748 $8.23 Million
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $358,853 - $445,236
2,719 New
2,719 $441,000
Q4 2021

Feb 02, 2022

SELL
$107.43 - $135.93 $347,965 - $440,277
-3,239 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $344,629 - $391,206
3,239 New
3,239 $349,000
Q4 2020

Feb 10, 2021

SELL
$80.49 - $108.67 $4.26 Million - $5.75 Million
-52,936 Closed
0 $0
Q3 2020

Nov 10, 2020

SELL
$85.91 - $100.83 $15,034 - $17,645
-175 Reduced 0.33%
52,936 $4.64 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $625,405 - $836,886
8,524 Added 19.12%
53,111 $5.21 Million
Q1 2020

Apr 30, 2020

BUY
$64.5 - $97.79 $334,174 - $506,649
5,181 Added 13.15%
44,587 $3.4 Million
Q4 2019

Feb 03, 2020

SELL
$72.13 - $90.25 $13,704 - $17,147
-190 Reduced 0.48%
39,406 $3.49 Million
Q3 2019

Nov 08, 2019

BUY
$62.98 - $75.72 $1.57 Million - $1.89 Million
24,935 Added 170.08%
39,596 $3 Million
Q2 2019

Aug 07, 2019

BUY
$65.7 - $83.98 $611,929 - $782,189
9,314 Added 174.19%
14,661 $1.07 Million
Q1 2019

May 02, 2019

SELL
$77.14 - $90.79 $5.88 Million - $6.92 Million
-76,193 Reduced 93.44%
5,347 $431,000
Q4 2018

Jan 31, 2019

BUY
$77.85 - $96.01 $68,118 - $84,008
875 Added 1.08%
81,540 $7.52 Million
Q3 2018

Nov 07, 2018

BUY
$88.91 - $98.84 $14,670 - $16,308
165 Added 0.2%
80,665 $7.63 Million
Q2 2018

Aug 09, 2018

BUY
$89.78 - $106.23 $149,842 - $177,297
1,669 Added 2.12%
80,500 $7.46 Million
Q1 2018

May 09, 2018

SELL
$92.01 - $123.21 $634,408 - $849,532
-6,895 Reduced 8.04%
78,831 $7.46 Million
Q4 2017

Feb 09, 2018

SELL
$89.56 - $98.21 $2.36 Million - $2.59 Million
-26,349 Reduced 23.51%
85,726 $8.29 Million
Q3 2017

Nov 07, 2017

BUY
$69.85 - $89.22 $6,984 - $8,922
100 Added 0.09%
112,075 $9.96 Million
Q2 2017

Aug 09, 2017

BUY
N/A
111,975
111,975 $8.12 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $341B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Banque Pictet & Cie Sa Portfolio

Follow Banque Pictet & Cie Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.